Status:

COMPLETED

Memantine Treatment of Compulsive Buying

Lead Sponsor:

University of Minnesota

Conditions:

Compulsive Buying

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.

Detailed Description

The goal of the proposed study is to evaluate the efficacy of memantine in the treatment of compulsive buying. Sixteen subjects meeting criteria for compulsive buying will receive 8 weeks of open-labe...

Eligibility Criteria

Inclusion

  • men and women age 18-65
  • current CB using the clinician-administered Structured Clinical Interview for Compulsive buying (SCI-CB)
  • buying behavior within 2 weeks prior to enrollment

Exclusion

  • infrequent buying (i.e. less than one time per week) that does not meet proposed criteria for CB
  • unstable medical illness or clinically significant abnormalities on laboratory tests or physical examination at screen
  • history of seizures
  • myocardial infarction within 6 months
  • current pregnancy or lactation, or inadequate contraception in women of childbearing potential
  • a need for medication other than memantine with possible psychotropic effects or unfavorable interactions;
  • clinically significant suicidality;
  • current Axis I disorder determined by the SCID and SCID-compatible modules for impulse control disorders, except for nicotine dependence
  • lifetime history of bipolar disorder type I or II, dementia, schizophrenia, or any psychotic disorder determined by SCID
  • current or recent (past 3 months) DSM-IV substance abuse or dependence;
  • positive urine drug screen at screening
  • initiation of psychotherapy or behavior therapy within 3 months prior to study baseline
  • previous treatment with memantine
  • treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline

Key Trial Info

Start Date :

December 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00830375

Start Date

December 1 2008

End Date

August 1 2010

Last Update

July 29 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ambulatory Research Center

Minneapolis, Minnesota, United States, 55454

2

University of Minnesota

Minneapolis, Minnesota, United States, 55454

Memantine Treatment of Compulsive Buying | DecenTrialz